C2i Genomics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 64

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $100M

C2i Genomics General Information

Description

Developer of a cancer treatment intelligence platform designed to improve cancer patients' lives and outcomes by monitoring cancer recurrence. The company's technology permits physicians to monitor patient treatment response and detect treatment failure or disease recurrence by analyzing subtle changes in the pattern of the tumor's DNA, providing oncologists with vital timely information long before current monitoring methods.

Contact Information

Website
www.c2i-genomics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 180 Varick Street
  • 6th Floor
  • New York, NY 10014
  • United States
Primary Industry
Decision/Risk Analysis
Acquirer
Veracyte
Vertical(s)
SaaS, HealthTech, Life Sciences, Oncology
Corporate Office
  • 180 Varick Street
  • 6th Floor
  • New York, NY 10014
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

C2i Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 05-Feb-2024 $100M Completed Generating Revenue
5. Accelerator/Incubator 13-Jul-2021 Completed Generating Revenue
4. Early Stage VC (Series B) 14-Apr-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 24-May-2020 Completed Generating Revenue
2. Accelerator/Incubator 18-Oct-2019 $1.2M Completed Generating Revenue
1. Seed Round 01-Aug-2019 $1.2M $1.2M Completed Generating Revenue
To view C2i Genomics’s complete valuation and funding history, request access »

C2i Genomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Seed
To view C2i Genomics’s complete cap table history, request access »

C2i Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cancer treatment intelligence platform designed to improve cancer patients' lives and outcomes by monitor
Decision/Risk Analysis
New York, NY
64 As of 2023

San Diego, CA
 

Madison, WI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

C2i Genomics Competitors (18)

One of C2i Genomics’s 18 competitors is CureMetrix, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CureMetrix Venture Capital-Backed San Diego, CA
HealthMyne Formerly VC-backed Madison, WI
InsightRx Venture Capital-Backed San Francisco, CA
Paige Venture Capital-Backed New York, NY
Proscia Venture Capital-Backed Philadelphia, PA
You’re viewing 5 of 18 competitors. Get the full list »

C2i Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

C2i Genomics Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Casdin Capital Venture Capital Minority
Driehaus Capital Management Corporation Minority
Duquesne Family Office Family Office Minority
Duquesne Fund Services Corporation Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

C2i Genomics FAQs

  • When was C2i Genomics founded?

    C2i Genomics was founded in 2019.

  • Where is C2i Genomics headquartered?

    C2i Genomics is headquartered in New York, NY.

  • What is the size of C2i Genomics?

    C2i Genomics has 64 total employees.

  • What industry is C2i Genomics in?

    C2i Genomics’s primary industry is Decision/Risk Analysis.

  • Is C2i Genomics a private or public company?

    C2i Genomics is a Private company.

  • What is the current valuation of C2i Genomics?

    The current valuation of C2i Genomics is .

  • What is C2i Genomics’s current revenue?

    The current revenue for C2i Genomics is .

  • How much funding has C2i Genomics raised over time?

    C2i Genomics has raised $113M.

  • Who are C2i Genomics’s investors?

    Alexandria Venture Investments, Casdin Capital, Driehaus Capital Management, Duquesne Family Office, and Duquesne Fund Services are 5 of 16 investors who have invested in C2i Genomics.

  • Who are C2i Genomics’s competitors?

    CureMetrix, HealthMyne, InsightRx, Paige, and Proscia are some of the 18 competitors of C2i Genomics.

  • When was C2i Genomics acquired?

    C2i Genomics was acquired on 05-Feb-2024.

  • Who acquired C2i Genomics?

    C2i Genomics was acquired by Veracyte.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »